Vergent Bioscience Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$22.1M
- Investors
-
7
Vergent Bioscience General Information
Description
Developer of molecular imaging probes designed for the diagnosis and removal of cancer cells. The company develops molecularly-targeted probes that bind to enzymes that are over-expressed in tumor tissue, activating a brightly fluorescing dye when injected prior to surgery, enabling surgeons to locate and completely remove tumors during resection surgery through improved visual clarity.
Contact Information
Website
www.vergentbio.comCorporate Office
- 5810 West 78th Street
- Suite 222
- Minneapolis, MN 55439
- United States
Corporate Office
- 5810 West 78th Street
- Suite 222
- Minneapolis, MN 55439
- United States
Vergent Bioscience Timeline
Vergent Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 04-Oct-2022 | $22.1M | Completed | Clinical Trials - Phase 1 | ||
| 2. Grant | 08-Sep-2022 | Completed | Clinical Trials - Phase 1 | |||
| 1. Later Stage VC (Series A) | 23-Sep-2020 | $11.9M | $11.9M | Completed | Pre-Clinical Trials |
Vergent Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Founders | 7,000,000 | $0.000100 | $0.03 | $0.65 | $0.65 | 1x | $0.65 | 8.38% |
Vergent Bioscience Comparisons
Industry
Financing
Details
Vergent Bioscience Competitors (13)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genomic Expression | Venture Capital-Backed | Beverly, MA | ||||
| Exosome Diagnostics | Formerly VC-backed | Waltham, MA | ||||
| Epic Sciences | Venture Capital-Backed | San Diego, CA | ||||
| Aurora Biopharma | Angel-Backed | New York, NY | ||||
| AgomAb | Venture Capital-Backed | Antwerp, Belgium |
Vergent Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vergent Bioscience Patents
Vergent Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023215269-A1 | Methods for localization of cancerous tissue using fluorescent molecular imaging agent for diagnosis or treatment | Pending | 02-Feb-2022 |
Vergent Bioscience Executive Team (5)
| Name | Title | Board Seat |
|---|---|---|
| John Santini Ph.D | Chief Executive Officer, President & Board Member | |
| Jeffrey Yurecko | Chief Financial Officer | |
| Jeffrey Julkowski | Co-Founder & Board Member | |
| Samuel Banks | Co-Founder & Board Member | |
| Curtis Scribner MD | Chief Medical Officer |
Vergent Bioscience Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Douglas Kohrs | Self | Board Member | |
| Jeffrey Julkowski | Self | Co-Founder & Board Member | |
| Margo Shoup MD | Orlando Health | Board Member | |
| Raymond Wong | Spring Mountain Capital | Board Member | |
| Robert Helmedag | Orlando Health Ventures | Board Member |
Vergent Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vergent Bioscience Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Intuitive Surgical | Corporation | Minority | ||
| Orlando Health Ventures | Corporate Venture Capital | Minority | ||
| Rex Health Ventures | Corporate Venture Capital | Minority | ||
| Windham Capital Partners | Venture Capital | Minority | ||
| National Institutes of Health | Government |
Vergent Bioscience FAQs
-
When was Vergent Bioscience founded?
Vergent Bioscience was founded in 2013.
-
Who is the founder of Vergent Bioscience?
Jeffrey Julkowski and Samuel Banks are the founders of Vergent Bioscience.
-
Who is the CEO of Vergent Bioscience?
John Santini Ph.D is the CEO of Vergent Bioscience.
-
Where is Vergent Bioscience headquartered?
Vergent Bioscience is headquartered in Minneapolis, MN.
-
What is the size of Vergent Bioscience?
Vergent Bioscience has 10 total employees.
-
What industry is Vergent Bioscience in?
Vergent Bioscience’s primary industry is Surgical Devices.
-
Is Vergent Bioscience a private or public company?
Vergent Bioscience is a Private company.
-
What is the current valuation of Vergent Bioscience?
The current valuation of Vergent Bioscience is .
-
What is Vergent Bioscience’s current revenue?
The current revenue for Vergent Bioscience is .
-
How much funding has Vergent Bioscience raised over time?
Vergent Bioscience has raised $34M.
-
Who are Vergent Bioscience’s investors?
Intuitive Surgical, Orlando Health Ventures, Rex Health Ventures, Windham Capital Partners, and National Institutes of Health are 5 of 7 investors who have invested in Vergent Bioscience.
-
Who are Vergent Bioscience’s competitors?
Genomic Expression, Exosome Diagnostics, Epic Sciences, Aurora Biopharma, and AgomAb are some of the 13 competitors of Vergent Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
